Charles Williams
Director of Finance/CFO bei SURROZEN, INC.
Vermögen: 23 157 $ am 31.03.2024
Profil
Charles Williams is currently the Chief Operating & Financial Officer at Surrozen, Inc. He previously worked as the Director-Corporate & Business Development at MAP Pharmaceuticals LLC from 2008 to 2013, and as the Head-Corporate Development at Jazz Pharmaceuticals Plc from 2013 to 2020.
Mr. Williams completed his undergraduate degree at Cornell University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SURROZEN INC
0,07% | 04.04.2024 | 1 474 ( 0,07% ) | 23 157 $ | 31.03.2024 |
Aktive Positionen von Charles Williams
Unternehmen | Position | Beginn |
---|---|---|
SURROZEN, INC. | Director of Finance/CFO | 01.11.2020 |
Ehemalige bekannte Positionen von Charles Williams
Unternehmen | Position | Ende |
---|---|---|
JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01.11.2020 |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Corporate Officer/Principal | 01.01.2013 |
Ausbildung von Charles Williams
Cornell University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
JAZZ PHARMACEUTICALS PLC | Health Technology |
SURROZEN, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Health Technology |